GlassScriptPhysician profile
Katie P Bordonaro
NPI 1245633874
$47,809.87
in general payments reported to CMS, 2019-2025
16 companies · $4,701 in 2025
The $4,701 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,342 · 2022: $6,765 · 2023: $20K · 2024: $13K · 2025: $4,701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $10K · Consulting Fee: $5,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,601.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,560.00 |
| Food and Beverage | $10,166.44 |
| Consulting Fee | $5,375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32,890.53 | 2021-2025 | Linq II, Micra, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $11,831.01 | 2021-2025 | Emblem Mri S-Icd, General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Impulse Dynamics (USA) INC. | $1,084.01 | 2024-2025 | Optimizer |
| Abbott Laboratories | $717.08 | 2021-2025 | Aveir, Ensite |
| Biotronik INC. | $511.06 | 2021 | |
| Pfizer INC. | $232.39 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $129.87 | 2021-2024 | Lifevest |
| Biosense Webster, INC. | $116.61 | 2022-2024 | Carto 3 |
| Inspire Medical Systems, INC. | $116.21 | 2024-2025 | Inspire |
| Philips North America LLC | $41.87 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $37.27 | 2022-2023 | Eliquis |
| Sanofi-Aventis U.S. LLC | $27.74 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $24.69 | 2023 | Andexxa |
| Elutia, INC. | $19.35 | 2021 | |
| Altathera Pharmaceuticals LLC | $16.72 | 2025 | Sotalol Hydrochloride |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $13.46 | 2023 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Bordonaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.